CellSource Income Statement

Financials in millions JPY. Fiscal year is November - October.

Millions JPY. Fiscal year is Nov - Oct.

Fiscal Year	FY 2025	FY 2023	FY 2022
Period Ending	Oct '25 Oct 31, 2025	Oct '23 Oct 31, 2023	Oct '22 Oct 31, 2022
Revenue	3,711	4,511	4,274
Revenue Growth (YoY)	-17.73%	5.54%	-
Cost of Revenue	1,624	1,326	1,210
Gross Profit	2,087	3,185	3,064
Selling, General & Admin	1,920	1,136	812.85
Research & Development	-	72.45	87.56
Other Operating Expenses	-	733.79	575.73
Operating Expenses	1,920	1,963	1,493
Operating Income	167	1,222	1,571
Interest Expense	-1	-0.38	-0.01
Interest & Investment Income	-	0.01	0.01
Earnings From Equity Investments	-	-3.08	-3.16
Currency Exchange Gain (Loss)	-	-8.4	20.63
Other Non Operating Income (Expenses)	-1	-13.58	4.67
EBT Excluding Unusual Items	165	1,196	1,593
Gain (Loss) on Sale of Investments	-13	33	-9.55
Gain (Loss) on Sale of Assets	2	-	-
Other Unusual Items	-45	10.6	-
Pretax Income	109	1,240	1,584
Income Tax Expense	99	316.54	565.8
Net Income	10	923.14	1,018
Net Income to Common	10	923.14	1,018
Net Income Growth	-98.92%	-9.30%	-
Shares Outstanding (Basic)	20	19	19
Shares Outstanding (Diluted)	20	19	19
Shares Change (YoY)	2.88%	0.25%	-
EPS (Basic)	0.50	48.88	54.54
EPS (Diluted)	0.50	47.93	52.98
EPS Growth	-98.95%	-9.53%	-
Free Cash Flow	290	498.62	752.89
Free Cash Flow Per Share	14.64	25.89	39.19
Dividend Per Share	-	5.000	-
Gross Margin	56.24%	70.61%	71.70%
Operating Margin	4.50%	27.08%	36.76%
Profit Margin	0.27%	20.47%	23.82%
Free Cash Flow Margin	7.81%	11.05%	17.62%
EBITDA	384	1,285	1,616
EBITDA Margin	10.35%	28.50%	37.82%
D&A For EBITDA	217	63.85	45.42
EBIT	167	1,222	1,571
EBIT Margin	4.50%	27.08%	36.76%
Effective Tax Rate	90.83%	25.53%	35.73%
Advertising Expenses	-	32.81	39.44

Source: S&P Global Market Intelligence. Standard template. Financial Sources.